Dorsch W, Waldherr U, Rosmanith J
Pflugers Arch. 1981 Sep;391(3):236-41. doi: 10.1007/BF00596177.
The method presented is based on whole-body plethysmography. The apparatus consisted of two chambers (a = respiratory, b = body chamber) separated by a tight water-filled rubber cuff which was fixed around the head of the animal. Experiments were performed under constant gas conditions: temperature 30 degrees C, 100% relative humidity, the volumes of the two chamber being identical. Volume changes in the chamber (delta Va, delta Vb) were recorded continuously by means of pressure transducers. Respiratory flow was calculated by differentiation of delta Va with respect to time. The three parameters delta Va, delta Vb and respiratory flow allowed the calculation of breathing frequency, inspiration/expiration ratio, (peak) expiratory flow and specific airway conductance. In addition we describe a new parameter indicating bronchial obstruction: a graphical plot of delta Vb against delta Va produces a closed loop, the area of which reflects the degree of airway obstruction, and we read off the parameter we term "compressed air" from this graph. In our hands this parameter was more than ten times as sensitive as other measures of bronchial obstruction. Using this new technique we have carried out pharmacological studies with eicosatetraynoic acid (ETYA), 2-aminomethyl 4-t-butyl-6-iodophenol (MK 447 = radical scavenger), the histamine antagonist clemastine and the histamine antagonist cimetidine. In allergen-tested animals we observed mild protective effects of ETYA when given as an aerosol (3 mg) and pronounced effects of MK 447 (4 mg i.p.). Combined H1 H2-antagonism was much more effective in preventing allergen-induced bronchial obstruction than H1-antagonism alone.
所介绍的方法基于全身体积描记法。该装置由两个腔室(a = 呼吸腔,b = 体腔)组成,中间由一个紧密的充水橡胶袖带隔开,该袖带固定在动物头部周围。实验在恒定气体条件下进行:温度30摄氏度,相对湿度100%,两个腔室的体积相同。腔室内的体积变化(ΔVa,ΔVb)通过压力传感器连续记录。呼吸流量通过对ΔVa关于时间求导来计算。ΔVa、ΔVb和呼吸流量这三个参数可用于计算呼吸频率、吸气/呼气比、(峰值)呼气流量和比气道传导率。此外,我们描述了一个指示支气管阻塞的新参数:ΔVb对ΔVa的图形绘制会产生一个闭环,其面积反映气道阻塞程度,我们从该图中读出我们称为“压缩空气”的参数。在我们的实验中,该参数对支气管阻塞的敏感性比其他测量方法高十多倍。使用这项新技术,我们用二十碳四炔酸(ETYA)、2 - 氨基甲基 - 4 - 叔丁基 - 6 - 碘苯酚(MK 447 = 自由基清除剂)、组胺拮抗剂氯马斯汀和组胺拮抗剂西咪替丁进行了药理学研究。在经过过敏原测试的动物中,我们观察到ETYA以气雾剂形式给药(3毫克)时有轻微的保护作用,MK 447(4毫克腹腔注射)有显著作用。联合H1H2拮抗剂在预防过敏原诱导的支气管阻塞方面比单独的H1拮抗剂更有效。